|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
160713523X |
| 003 |
DE-627 |
| 005 |
20230426161324.0 |
| 007 |
tu |
| 008 |
991123s1999 sw ||||| m 00| ||eng c |
| 020 |
|
|
|a 9155445462
|9 91-554-4546-2
|
| 035 |
|
|
|a (DE-627)160713523X
|
| 035 |
|
|
|a (DE-576)081845146
|
| 035 |
|
|
|a (DE-599)BSZ081845146
|
| 035 |
|
|
|a (OCoLC)247465306
|
| 035 |
|
|
|a (OCoLC)186074147
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-SE
|
| 084 |
|
|
|a 44.75
|2 bkl
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 100 |
1 |
|
|a Andersson, Hans Ola
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Structure-aided design of antiviral drugs
|b application of the method on HIV-1 protease and SIV reverse transcriptase
|c by Hans Ola Andersson
|
| 264 |
|
1 |
|a Uppsala
|b University
|c 1999
|
| 300 |
|
|
|a 50 S.
|b graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Acta Universitatis Upsaliensis
|a Comprehensive summaries of Uppsala dissertations from the Faculty of Science and Technology
|v 477
|
| 502 |
|
|
|a Vollst. zugl.: Uppsala, Univ., Diss., 1999
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 2
|2 pdager
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4139555-4
|0 (DE-627)104248289
|0 (DE-576)20969534X
|a Viruzid
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4200792-6
|0 (DE-627)10410497X
|0 (DE-576)210137967
|a HIV
|2 gnd
|
| 689 |
0 |
2 |
|D s
|0 (DE-588)4047521-9
|0 (DE-627)106194364
|0 (DE-576)209073837
|a Proteasen
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 751 |
|
|
|a Uppsala
|0 (DE-588)4078659-6
|0 (DE-627)106076744
|0 (DE-576)209209488
|4 uvp
|
| 810 |
2 |
|
|a Uppsala universitet
|b Teknisk-naturvetenskapliga fakulteten
|t Comprehensive summaries of Uppsala dissertations from the Faculty of Science and Technology
|v 477
|9 477
|w (DE-627)182294927
|w (DE-576)036834270
|w (DE-600)1194708-1
|x 1104-232X
|7 ns
|
| 889 |
|
|
|w (DE-627)305040006
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a ISIL_DE-7
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a ISIL_DE-89
|
| 912 |
|
|
|a GBV_ILN_2015
|
| 912 |
|
|
|a ISIL_DE-93
|
| 912 |
|
|
|a GBV_ILN_2021
|
| 912 |
|
|
|a ISIL_DE-289
|
| 935 |
|
|
|i mdedup
|
| 936 |
b |
k |
|a 44.75
|j Infektionskrankheiten
|j parasitäre Krankheiten
|x Medizin
|0 (DE-627)106415948
|
| 936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 40
|1 01
|x 0007
|b 364263369
|c 00
|f --%%--
|d K 99 A 2681
|e u
|j --%%--
|y xsn
|z 24-01-00
|
| 980 |
|
|
|2 70
|1 01
|x 0089
|b 372876285
|c 00
|f Haus2
|d RA 9970(477)
|e u
|j --%%--
|y z
|z 03-01-00
|
| 980 |
|
|
|2 2015
|1 01
|x DE-93
|b 3126508707
|c 00
|f --%%--
|d Diss. 1999/5222
|e --%%--
|j --%%--
|y l01
|z 23-11-99
|
| 980 |
|
|
|2 2021
|1 01
|x DE-289
|b 3126508774
|c 00
|f W
|d H 209.417
|e --%%--
|j --%%--
|y l01
|z 09-04-02
|
| 984 |
|
|
|2 40
|1 01
|x 0007
|a 7$206703384
|
| 984 |
|
|
|2 70
|1 01
|x 0089
|a 89$120570874
|
